Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB A031203 Principal Investigator: Picus, Joel
Title: Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma
Phase: II Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out what effects, good and/or bad, two study drugs called sunitinib and cabozantinib have on advanced or metastatic kidney cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)